Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastomaYoshihiro Otani, Yeshavanth Banasavadi‐Siddegowda, Dragan Maric et al.|Neuro-Oncology|2021Cited by 34
Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinibYeshavanth Banasavadi‐Siddegowda, Balveen Kaur, Sriya Namagiri et al.|Neuro-Oncology Advances|2022Cited by 13
CSIG-17. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENTYoshihiro Otani, Yeshavanth Banasavadi‐Siddegowda, Sriya Namagiri et al.|Neuro-Oncology|2020Cited by 0
DDRE-26. INHIBITION OF PRMT5 SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENTYesh Banasavadi, Balveen Kaur, Sriya Namagiri et al.|Neuro-Oncology|2021Cited by 0
STEM-23. INHIBITING PROTEIN PHOSPHATASE 2A INCREASES THE ANTITUMOR EFFECT OF PROTEIN ARGININE METHYLTRANSFERASE 5 INHIBITION IN MODELS OF GLIOBLASTOMAYeshavanth Kumar Banasavadi Siddegowda, Balveen Kaur, Hannah Sur et al.|Neuro-Oncology|2020Cited by 0